Non-potassium-sparing diuretics and beta blockers increase risk for sudden cardiac death, Dutch study finds.
Executive Summary
NON-POTASSIUM-SPARING DIURETICS AND BETA BLOCKERS INCREASE RISK OF SUDDEN DEATH by myocardial infarction, according to a study published in the Oct. 1 Annals of Internal Medicine. The study, conducted at Erasmus University Medical School, Rotterdam, Netherlands by Arno Hoes, MD, et al., warns that the association between non-potassium-sparing diuretics and beta blockers and sudden cardiac death "may offset part of the mortality benefit of these drugs in the treatment of hypertension."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth